Precision nanomedicine-based diagnostics and therapeutics for refractory malignancies

  • Kavallaris, Maria (Primary Chief Investigator (PCI))
  • Davis, Thomas (Chief Investigator (CI))
  • Lock, Richard B (Chief Investigator (CI))
  • Gooding, John Justin (Chief Investigator (CI))

Project: Research

StatusActive
Effective start/end date1/01/1631/12/20

Funding

  • National Health & Medical Research Council (NHMRC): AUD7,088,520.00